Skip to main content

Advertisement

Log in

Inflammation, Nutrition, and Clinical Outcomes in Breast Cancer Survivors: A Narrative Review

  • REVIEW
  • Published:
Current Nutrition Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Breast cancer (BC) is the leading cause of death among women aged 44–55 years globally. Pro-inflammatory food can cause tissue-level inflammation, thereby creating a carcinogenic microenvironment and promoting breast cancer. The aim of this review is to provide an overview of the association between inflammation and nutrition and clinical outcomes in breast cancer survivors.

Recent Findings

Pro-inflammatory diets are associated with a higher mortality risk after diagnosis and worse prognosis after treatment. On the other hand, anti-inflammatory diets may improve tissue-level inflammation and improve the overall prognosis and quality of life of survivors. There is strong evidence that the Mediterranean diet in particular is associated with reduced recurrence risk of breast cancer and improved quality of life of survivors.

Summary

This narrative review provides evidence that there is a strong association between inflammation, dietary habits, and adverse clinical outcomes in breast cancer survivors. It further discusses the current evidence for the role of dietary management in improving clinical outcomes in breast cancer survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:   • Of importance   •• Of major importance

  1. Breast Cancer Research Foundation (BCRF). Breast cancer statistics and resources. 2020. https://www.bcrf.org/breast-cancer-statistics-and-resources/.

  2. World Health Organization (WHO). Cancer Today, Lyon, France: International Agency for Research on Cancer. 2020. https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf.

  3. Caprara G, Tieri M, Fabi A, Guarneri V, Falci C, Dieci M, et al. Corrigendum: results of the echo (eating habits changes in oncologic patients) survey: an Italian cross-sectional multicentric study to explore dietary changes and dietary supplement use, in breast cancer survivors. Front Oncol. 2022;12(11): 705927.

    Google Scholar 

  4. National Cancer Institute (NCI), n.d. NCI Dictionaries. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivor.

  5. American Cancer society (ACS). Breast Cancer Stages. 2021. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/stages-of-breast-cancer.html.

  6. Alkabban M, Ferguson T. Breast Cancer. StatPearls Publishing Treasure Island (FL): StatPearls Publishing. 2021. https://www.ncbi.nlm.nih.gov/books/NBK482286/.

  7. American Cancer Society. Breast Cancer Stages. 2021. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/stages-of-breast-cancer.html.

  8. Czajka L, Pfeifer C. Breast Cancer Surgery. StatPearls Publishing. 2020. https://www.ncbi.nlm.nih.gov/books/NBK553076/.

  9. World Health Organization (WHO). Obesity and overweight. 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

  10. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer Nature reviews Disease primers. 2019;5(1):66. https://doi.org/10.1038/s41572-019-0111-2.

    Article  PubMed  Google Scholar 

  11. Weiss M, Wojciechowski B, Gupta S. Recurrent Breast Cancer. 2021. https://www.breastcancer.org/symptoms/types/recurrent.

  12. Sheng J. Recurrent Breast Cancer. 2022. https://www.breastcancer.org/types/recurrent.

  13. Aamir A. Pathways to Breast Cancer Recurrence, International Scholarly Research Notices. 2013; Article ID 290568(16pages). https://doi.org/10.1155/2013/290568.

  14. Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases. 2015;5(2):77–106. https://doi.org/10.1016/j.gendis.2018.05.001.

    Article  CAS  Google Scholar 

  15. Susan G. Komen, 2021. Breast Cancer Recurrence. https://www.komen.org/breast-cancer/treatment/recurrence/.

  16. • Pedersen R, Esen B, Mellemkjær L, Christiansen P, Ejlertsen B, Lash, L, et al. The incidence of breast cancer recurrence 10–32 years after primary diagnosis. J Natl Cancer Inst. 2022;114(3):391–399. https://doi.org/10.1093/jnci/djab202. This article provides epidemiological information on late-recurrent BC and demonstrates risk factors associated with BC recurrence.

  17. Jin X, Mu P. Targeting Breast Cancer Metastasis. Breast Cancer Basic Clin Res. 2015;9(S1):23–34. https://doi.org/10.4137/BCBCR.S25460.

    Article  Google Scholar 

  18. • Lafourcade A, His M, Baglietto L, Boutron-Ruault M. C, Dossus L, Rondeau V. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort. BMC cancer, 2018;18(1):171. https://doi.org/10.1186/s12885-018-4076-4 . This study demonstrated the importance of baseline lifestyle characteristics on BC relapse and mortality predictability in order to better guide individualized BC management.

  19. Riggio A, Varley K, Welm A. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13–26. https://doi.org/10.1038/s41416-020-01161-4.

    Article  PubMed  Google Scholar 

  20. Muk H, Chang-Gue S. The risk of psychological stress on cancer recurrence: a systematic Review. Cancers. 2021;13(22):5816. https://doi.org/10.3390/cancers13225816.

    Article  Google Scholar 

  21. Okada F. Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms. Yonago acta medica. 2014;57(2):65–72. https://pubmed.ncbi.nlm.nih.gov/25324587.

  22. Singh N, Baby D, Rajguru J, Patil P, Thakkannavar S, Pujari V. Inflammation and cancer. Ann Afr Med. 2019;18(3):121–6. https://doi.org/10.4103/aam.aam_56_18.

    Article  PubMed  PubMed Central  Google Scholar 

  23. •• Mourouti N, Kontogianni M, Papavagelis C, Panagiotakos D. Diet and breast cancer: a systematic review. Int j food sci nutr. 2015;66(1):1–42. https://doi.org/10.3109/09637486.2014.950207. This paper provides a comprehensive summary of in the association between nutrition and breast cancer risk, progression and recurrence.

  24. Greten F, Grivennikov S. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. https://doi.org/10.1016/j.immuni.2019.06.025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Hébert R, Shivappa N, Wirth D, Hussey R, Hurley G. Perspective: the dietary inflammatory index (DII)-lessons learned, improvements made, and future directions. Adv Nutr. 2019;10(2):185–95. https://doi.org/10.1093/advances/nmy071.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jandari S, Mosalmanzadeh N, Moghadam M, Soleimani D, Shivappa N, Hebert J. Dietary inflammatory index and healthy eating index-2015 are associated with rheumatoid arthritis: Public Health Nutrition. Cambridge Core Cambridge University Press. 2021;24(18):6007–14. https://doi.org/10.1017/S1368980021001105.

    Article  Google Scholar 

  27. American Institute for Cancer Research (AICR). Anti-inflammatory diet may lower risk of mortality from heart disease among breast cancer survivors. 2016. https://www.aicr.org/resources/blog/anti-inflammatory-diet-may-lower-risk-of-mortality-among-women-diagnosed-with-breast-cancer/.

  28. Haykowsky J, Scott M, Hudson K, Denduluri N. Lifestyle interventions to improve cardiorespiratory fitness and reduce breast cancer recurrence. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2017;37:57–64. https://doi.org/10.1200/EDBK_175349.

  29. Kim J, Yoon L, Park J, Sung M. Estrogen deprivation and excess energy supply accelerate 7,12-dimethylbenz (a) anthracene-induced mammary tumor growth in C3H/HeN mice. Nutrition Res Prac. 2015;9:628–36. https://pubmed.ncbi.nlm.nih.gov/26634052/.

  30. Jiang Y, Pan Y, Rhea P, Tan L, Gagea M, Cohen L. A sucrose-enriched diet promotes tumorigenesis in mammary gland in part through the 12-lipoxygenase pathway. Cancer Res 2016;76:24–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703949/.

  31. World Cancer Research Fund/American Institute for Cancer (WCRF/AIC), 2018. World Cancer Research Fund, Third Expert Report. https://www.wcrf.org/dietandcancer/breast-cancer/.

  32. Ubago-Guisado E, Rodríguez-Barranco M, Ching-López A, Petrova D, Molina-Montes E, Amiano P, et al. Evidence update on the relationship between diet and the most common cancers from the European prospective investigation into cancer and nutrition (EPIC) study: a systematic review. Nutrients. 2021;13(10):3582. https://doi.org/10.3390/nu13103582.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Guasch-Ferré M, Willett WC. The Mediterranean diet and health: a comprehensive overview. J Intern Med. 2021;290(3):549–66. https://doi.org/10.1111/joim.13333.

    Article  PubMed  Google Scholar 

  34. Mazzocchi A, Leone L, Agostoni C, Pali-Schöll I. The secrets of the Mediterranean diet. Does [Only] Olive Oil Matter. Nutrients. 2019; 1(12):2941. https://doi.org/10.3390/nu11122941.

  35. Forsyth C, Kouvari M, D’Cunha M, Georgousopoulou E, Panagiotakos D, Mellor D, et al. The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies. Rheumatol Int. 2018;38(5):737–47. https://doi.org/10.1007/s00296-017-3912-1.

    Article  PubMed  Google Scholar 

  36. Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean diet; a literature review. Nutrients. 2015;7(11):9139–53. https://doi.org/10.3390/nu7115459.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Trichopoulou A, Martínez-González M, Tong T, Forouhi N, Khandelwal S. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med. 2014;12:112. https://doi.org/10.1186/1741-7015-12-112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Masala G, Assedi M, Bendinelli B, Ermini I, Sieri S, Grioni S, et al. Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study. Breast Cancer Res Treat. 2012;132(3):1127–36. https://doi.org/10.1007/s10549-011-1939-7.

    Article  PubMed  Google Scholar 

  39. • Braakhuis A, Campion P, Bishop K. Reducing breast cancer recurrence: the role of dietary polyphenolics. Nutrients. 2016;8(9):547. https://doi.org/10.3390/nu8090547. Based on clinical and observational studies on the impact of polyphenolics in BCs, this paper provides dietary recommendations for survivors in order to promote survivorship.

  40. •• De Cicco P, Catani M, Gasperi V, Sibilano M, Quaglietta M, Savini I. Nutrition and breast cancer: a literature review on prevention, treatment and recurrence. Nutrients. 2019;11(7):1514. https://doi.org/10.3390/nu11071514. This article provides up-to-date information on the role of nutrition in prevention, treatment and recurrence of BC, with concentration on the role of Mediterranean diet, weight goals, quality of life, and supplement intake.

  41. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(1):b2535–b2535. https://doi.org/10.1136/bmj.b2535.

    Article  PubMed  PubMed Central  Google Scholar 

  42. •• McAndrew N, Bottalico L, Mesaros C, Blair I, Tsao Y, Rosado J, et al. Effects of systemic inflammation on relapse in early breast cancer. NPJ breast cancer. 2021;7(1):7. https://doi.org/10.1038/s41523-020-00212-6. This study demonstrates that increased levels of serum CRP during adjuvant treatment in BCs is independently associated with an increased relapse risk in HR+/HER2- BC.

  43. •• Villaseñor A, Flatt S, Marinac C, Natarajan L, Pierce J, Patterson R. Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. 2014;23(1):189–199. https://doi.org/10.1158/1055-9965.EPI-13-0852This study provides evidence of the role of CRP as an independent biomarker for long-term BC survival.

  44. Pierce J, Faerber S, Wright F, Rock C, Newman V, Flatt S, et al. Women’s healthy eating and living (WHEL) study. UC San Diego Library Digital Collections. 2016. https://doi.org/10.6075/J0H12ZXW.

    Article  Google Scholar 

  45. Mikkelsen M, Lindblom N, Dhyl-Polk A, Juhl C, Johansen J, Nielsen D. Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer”. Crit Rev Clin Lab Sci. 2022;59(7):480–500. https://doi.org/10.1080/10408363.2022.2050886.

    Article  CAS  PubMed  Google Scholar 

  46. Ali H, Provenzano E, Dawson S, Blows F, Liu B, Shah M. Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients. Ann Oncol. 2014;25(8):1536–43. https://doi.org/10.1093/annonc/mdu191.

    Article  CAS  PubMed  Google Scholar 

  47. Wei B, et al. The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis. Onco Targets Ther. 2016;2016(9):5567–75. https://doi.org/10.2147/ott.s108419.

    Article  Google Scholar 

  48. Liu X, Qu J, Zhang J, Yan Y, Zhao X, Wang J, et al. Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients. Medicine. 2017;96(45). https://doi.org/10.1097/md.0000000000008101.

  49. Chen J, Pan Z, He B, Ying H, Sun H, Deng Q, et al. Meta-analysis of prognostic value of inflammation parameter in breast cancer. J Cancer Res Ther. 2018;14(8):85–9. https://doi.org/10.4103/0973-1482.160917.

    Article  Google Scholar 

  50. Xue L, Zong L, Bo Z, Yan Y, Dong Y, Li Z, et al. Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neo-adjuvant chemotherapy. Medicine. 2019;98(1): pe13842. https://doi.org/10.1097/md.0000000000013842.

  51. •• Foroutan-Ghaznavi M, Mazloomi S, Montazeri V, Pirouzpanah S. Dietary patterns in association with the expression of pro-metastatic genes in primary breast cancer. Eur J Nutr. 2022;61(6):3267–3284. https://doi.org/10.1007/s00394-022-02884-1. This study reported that adherence to a healthy dietary pattern is significantly associated with downregulation of genes implicated in pro-metastasis in BC survivors.

  52. George S, Ballard-Barbash R, Shikany J, Caan B, Freudenheim J, Kroenke C, et al. Better post-diagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the Women’s Health initiative. Cancer Epidemiol Biomark Prev. 2014;23(4):575–83. https://doi.org/10.1158/1055-9965.epi-13-1162.

    Article  Google Scholar 

  53. • McCullough L, Gapstur M, Shah R, Campbell T, Wang Y, Doyle C et al. Pre- and postdiagnostic diet in relation to mortality among breast cancer survivors in the CPS-II Nutrition Cohort. Cancer Causes & Control. 2016;27(11):1303–1314. 1. https://doi.org/10.1007/s10552-016-0802-x. This study provides evidence that adherence to the American Cancer Society guidelines for diet is not unassociated with BC-specific mortality.

  54. Jang H, Chung M, Kang S, Park Y. Association between the dietary inflammatory index and risk for cancer recurrence and mortality among patients with breast Cancer. Nutrients. 2018;10(8):1095. https://doi.org/10.3390/nu10081095.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. • Sun, Y, Bao W, Buyun L, Caan B, Lane D, Millen A, et al. Changes in overall diet quality in relation to survival in postmenopausal women with breast cancer: results from the Women’s Health initiative. Journal of the Academy of Nutrition and Dietetics. 2018;118(10):1855–1863. https://doi.org/10.1016/j.jand.2018.03.017. This paper concluded that decreased diet quality after BC diagnosis was associated with a higher BC-specific mortality risk.

  56. Wang L, Du S, Wang H, Popkin B. Influence of dietary fat intake on bodyweight and risk of obesity among Chinese adults, 1991–2015: a prospective cohort study. The Lancet. 2018; 392(S20). https://doi.org/10.1016/S0140-6736(18)32649-7.

  57. • Zheng J, Tabung F, Zhang J, Liese A, Shivappa N, Ockene J, et al. Association between post-cancer diagnosis dietary inflammatory potential and mortality among invasive breast cancer survivors in the women’s health initiative. Cancer Epidemiol Biomarkers Prev Am Assoc Cancer Res. 2018;27(4):454–463. https://doi.org/10.1158/1055-9965.EPI-17-0569. This paper exemplifies the positive impact between consumption of an anti-inflammatory diet and reduced risk of death from CVD in breast cancer survivors.

  58. •• Wang K, Sun J, Wu Q, Li Z, Li D, Xiong Y, et al. Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study. NPJ breast cancer. 2020;6:36. https://doi.org/10.1038/s41523-020-00179-4. This analysis found that a more anti-inflammatory diet after BC diagnosis is associated with a lower risk of all-cause mortality and BC-specific mortality in post-menopausal survivors.

  59. Ergas I, Cespedes E, Bradshaw P, Roh J, Kwan M, Cadenhead J, et al. Diet quality and breast cancer recurrence and survival: the pathways study. JNCI cancer spectrum. 2021;5(2):pkab019. https://doi.org/10.1093/jncics/pkab019.

  60. Wang T, Farvid M, Kang K, Holmes M, Rosner B, Tamimi R, et al. Diabetes risk reduction diet and survival after breast cancer diagnosis. Can Res. 2021;81(15):4155–62. https://doi.org/10.1158/0008-5472.can-21-0256.

    Article  CAS  Google Scholar 

  61. Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev. 2016;74(12):737–48. https://doi.org/10.1093/nutrit/nuw045.

    Article  PubMed  PubMed Central  Google Scholar 

  62. • Fowler M, Akinyemiju T. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017;141(11):2215–2227. https://doi.org/10.1002/ijc.30922. This study demonstrates the association between an increased DII and an increased risk of mortality in BCs.

  63. Castro-Espin C, Agudo A. The role of diet in prognosis among cancer survivors: a systematic review and meta-analysis of dietary patterns and diet interventions. Nutrients. 2022;14(2):348. https://doi.org/10.3390/nu14020348.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Porciello G, Montagnes C, Crispo A, Grimaldi M, Libra M. Mediterranean diet and quality of life in women treated for breast cancer: a baseline analysis of DEDiCa multicentre trial. PLOS ONE. 2021;16(8):e0256944. https://doi.org/10.1371/journal.pone.0239803.

  65. • Maso L, Maso L, Augustin A, Puppo A. Adherence to the Mediterranean diet and mortality after breast cancer. Nutrients. 2020;12(12):3649. https://doi.org/10.3390/nu12123649. This study reported that better adherence to a Mediterranean diet was associated with a better prognosis in regards to a 15-year survival rate in survivors.

  66. Castelló A, Boldo E, Pérez-Gómez B, Lope V, Altzibar J, Martín V, et al. Adherence to the Western, Prudent and Mediterranean dietary patterns and breast cancer risk: MCC-Spain study. Maturitas. 2017;103:8–15. https://doi.org/10.1016/j.maturitas.2017.06.020.

    Article  PubMed  Google Scholar 

  67. Weigl J, Hauner H, Hauner D. Can nutrition lower the risk of recurrence in breast cancer. Breast Care. 2018;13(2):86–91. https://doi.org/10.1159/000488718.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Rakicioglu N. Dietary advanced glycation end products, inflammation and oxidative stress in breast cancer patients. NCT04716764. 2021. https://clinicaltrials.gov/ct2/show/NCT04716764.

  69. Lee J. Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients. NCT04045392. 2019. https://clinicaltrials.gov/ct2/show/NCT04045392.

  70. Celentano E, Augustin L, Libra M. Diet, exercise and vitamin D in breast cancer recurrence (DEDiCa). NCT02786875. 2022. https://clinicaltrials.gov/ct2/show/NCT02786875.

  71. Cirauqui B, Berron S, Cebrian V, Lanza M, Agudo A. Prevention of breast cancer recurrence through weight control, diet, and physical activity intervention (PREDICOP). NCT02035631. 2014. https://clinicaltrials.gov/ct2/show/NCT02035631.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Constantina Constantinou.

Ethics declarations

Conflict of Interest

The authors do not have any potential conflicts of interest to disclose.

Human and Animal Rights and Informed Consent

As this was a review paper, no human or animal research was conducted by the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pannu, M.K., Constantinou, C. Inflammation, Nutrition, and Clinical Outcomes in Breast Cancer Survivors: A Narrative Review. Curr Nutr Rep 12, 643–661 (2023). https://doi.org/10.1007/s13668-023-00495-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13668-023-00495-8

Keywords

Navigation